INmune Bio logo
INmune Bio INMB
€ 1.22 -5.92%

Geschäftsbericht 2025
hinzugefügt 30.03.2026

report update icon

INmune Bio Abschreibung & Amortisation 2011-2026 | INMB

Abschreibung & Amortisation Jährlich INmune Bio

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
84 K - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
84 K 84 K 84 K

Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler

Name Abschreibung & Amortisation Preis % 24h Marktkapitalisierung Land
Compugen Ltd. Compugen Ltd.
CGEN
461 K $ 2.86 3.62 % $ 267 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
546 K $ 0.8 -3.59 % $ 36.6 M israelIsrael
Athira Pharma Athira Pharma
ATHA
972 K - - $ 269 M usaUSA
Exelixis Exelixis
EXEL
29.1 M $ 46.21 -5.11 % $ 12.5 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
403 K $ 2.4 -5.88 % $ 67 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
64 K $ 26.17 -1.32 % $ 339 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
66 K - - $ 231 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
920 K $ 22.56 5.03 % $ 3.74 B usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
105 K $ 3.14 -0.32 % $ 653 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
24 K $ 3.54 3.51 % $ 5.83 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
Genprex Genprex
GNPX
6.69 K $ 0.87 -2.84 % $ 811 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
22 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
13 K - 4.14 % $ 49.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
700 K $ 20.66 -14.52 % $ 2.63 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
363 K - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
122 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
3.13 M - - $ 10.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
597 K - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
1 K - 10.36 % $ 9.8 M usaUSA
Aravive Aravive
ARAV
886 K - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
487 K - 17.91 % $ 11.1 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
19.5 M $ 52.42 -4.83 % $ 4.71 B schweizSchweiz
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
8.3 M $ 1.61 -5.29 % $ 428 M britainBritain
Heron Therapeutics Heron Therapeutics
HRTX
2.31 M $ 1.24 -5.34 % $ 207 M usaUSA
AVROBIO AVROBIO
AVRO
617 K - 1083.1 % $ 745 M usaUSA